OAM
KURA icon

Oxford Asset Management’s Kura Oncology KURA Stock Holding History

Oxford Asset Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-25,346
Closed -$167K – 647
2025
Q1 		$167K Buy
+25,346
New +$198K 0.08% 380
2020
Q1 		– Sell
-134,566
Closed -$1.85M – 788
2019
Q4 		$1.85M Buy
134,566
+15,367
+13% +$228K 0.05% 465
2019
Q3 		$1.81M Sell
119,199
-40,904
-26% -$728K 0.04% 605
2019
Q2 		$3.15M Buy
160,103
+135,203
+543% +$2.24M 0.07% 438
2019
Q1 		$413K Buy
+24,900
New +$384K 0.01% 1296
2018
Q3 		– Sell
-23,610
Closed -$421K – 1824
2018
Q2 		$421K Sell
23,610
-39,800
-63% -$674K 0.01% 1402
2018
Q1 		$1.19M Buy
63,410
+29,444
+87% +$573K 0.03% 863
2017
Q4 		$516K Buy
+33,966
New +$501K 0.01% 1166
2017
Q3 		– Sell
-23,287
Closed -$217K – 1620
2017
Q2 		$217K Buy
+23,287
New +$212K ﹤0.01% 1339

Other funds holding KURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Oxford Asset Management's KURA Position: Q2 2025 in Review

Oxford Asset Management sold out of Kura Oncology (KURA) in Q2 2025, closing a stake of 25,346 shares — an estimated $167K sold.

Oxford Asset Management first reported a position in KURA in Q2 2017 and held it in 9 quarters. The position peaked at $3.15M in Q2 2019. 182 funds tracked by Wall St. Rank hold KURA as of Q2 2025.

  • Oxford Asset Management reported no remaining Kura Oncology position as of Q2 2025 after selling out during the quarter.
  • Oxford Asset Management sold 25,346 Kura Oncology shares in Q2 2025, an estimated $167K.
  • Oxford Asset Management first reported a position in Kura Oncology in Q2 2017 and held it in 9 quarters.
  • Oxford Asset Management's Kura Oncology position peaked at $3.15M in Q2 2019.
  • 182 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2025.

Based on Oxford Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.